Showing results (171-180 of 202) with videos related to

Sort By:
Pageof 21
European Heart Journal|September 26, 2015
A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†Fizzah Choudry, Stephen Hamshere, Natalie Saunders, et al.
Journal of Clinical Medicine|January 23, 2020
Pregnancy Associated Plasma Protein-A as a Cardiovascular Risk Marker in Patients with Stable Coronary Heart Disease During 10 Years Follow-Up-A CLARICOR Trial Sub-StudyErik Nilsson, Jens Kastrup, Ahmad Sajadieh, et al.
Stem Cells International|January 16, 2018
Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled StudyAbbas Ali Qayyum, Anders Bruun Mathiasen, Naja Dam Mygind, et al.
International Journal of Cardiology|November 22, 2016
Transthoracic Doppler echocardiography compared with positron emission tomography for assessment of coronary microvascular dysfunction: The iPOWER studyMarie Mide Michelsen, Naja Dam Mygind, Adam Pena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2025
Long-term Effectiveness and Safety of Mesenchymal Stromal Cell Therapy for Radiation-Induced Hyposalivation in Head and Neck Cancer Survivors: A Randomized Phase II TrialAmanda-Louise Fenger Carlander, Kathrine Kronberg Jakobsen, Tobias Todsen, et al.
Stem Cells Translational Medicine|September 8, 2017
Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety StudyJens Kastrup, Mandana Haack-Sørensen, Morten Juhl, et al.
Lancet (London, England)|October 1, 2013
Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trialStig-Frederik Trojahn Kølle, Anne Fischer-Nielsen, Anders Bruun Mathiasen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|March 21, 2019
Myocardial first pass perfusion assessed by cardiac magnetic resonance and coronary microvascular dysfunction in women with angina and no obstructive coronary artery diseaseNaja Dam Mygind, Adam Pena, Marie Mide Michelsen, et al.
American Heart Journal|March 25, 2014
Improving diagnosis and treatment of women with angina pectoris and microvascular disease: the iPOWER study design and rationaleEva Prescott, Steen Zabell Abildstrøm, Ahmed Aziz, et al.
Diagnostic Microbiology and Infectious Disease|March 16, 2010
Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trialJørgen Hilden, Inga Lind, Hans Jørn Kolmos, et al.
Pageof 21